Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

March 3, 2025

Study Completion Date

April 1, 2025

Conditions

Neovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema

Interventions

DRUG

AIV007

Periocular injection

Trial Locations (6)

Texas Retina Associates, Plano

Medical Center Ophthalmology, San Antonio

Valley Retina Institute, McAllen

Retina-Vitreous Associates, Beverly Hills

Orange County Retina, Santa Ana

Verum Research, Eugene